GAMMA Investing
AVXL icon

GAMMA Investing’s Anavex Life Sciences AVXL Stock Holding History

GAMMA Investing’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.38K Buy
1,179
+1,089
+1,210% +$3.01K ﹤0.01% 3896
2026
Q2 		$233 Sell
90
-290
-76% -$858 ﹤0.01% 4075
2026
Q1 		$1.17K Sell
380
-64
-14% -$277 ﹤0.01% 3807
2025
Q4 		$1.58K Sell
444
-1,011
-69% -$6.19K ﹤0.01% 3671
2025
Q3 		$13K Buy
1,455
+144
+11% +$1.46K ﹤0.01% 2746
2025
Q2 		$12.1K Sell
1,311
-1,490
-53% -$12.7K ﹤0.01% 2714
2025
Q1 		$24K Buy
2,801
+1,562
+126% +$14.8K ﹤0.01% 2275
2024
Q4 		$13.3K Buy
1,239
+631
+104% +$4.85K ﹤0.01% 2465
2024
Q3 		$3.45K Buy
608
+470
+341% +$2.71K ﹤0.01% 2884
2024
Q2 		$582 Sell
138
-64
-32% -$259 ﹤0.01% 3180
2024
Q1 		$1.03K Sell
202
-1,155
-85% -$6.5K ﹤0.01% 2934
2023
Q4 		$8.1K Buy
+1,357
New +$9.34K ﹤0.01% 2019

Other funds holding AVXL

Apella Capital
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
PVG Asset Management
PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return
LexAurum Advisors
LexAurum Advisors Overland Park, Kansas $893M AUM
Sheets Smith Wealth Management
Sheets Smith Wealth Management Winston-Salem, North Carolina $958M AUM 21.88% 1-Year Est. Return
Forum Financial Management
Forum Financial Management Lombard, Illinois $7.7B AUM 11.59% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Anchyra Partners
Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
BNC Wealth Management
BNC Wealth Management Beaverton, Oregon $436M AUM 37.7% 1-Year Est. Return

GAMMA Investing's AVXL Position: Q3 2026 in Review

GAMMA Investing increased its Anavex Life Sciences (AVXL) stake by 1,210% in Q3 2026, buying an estimated $3.01K and bringing the position to 1,179 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #3896.

GAMMA Investing first reported a position in AVXL in Q4 2023 and has held it in 12 quarters since. The position peaked at $24K in Q1 2025. 24 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • GAMMA Investing held 1,179 shares of Anavex Life Sciences worth $2.38K as of Q3 2026.
  • GAMMA Investing bought 1,089 Anavex Life Sciences shares in Q3 2026, an estimated $3.01K.
  • Anavex Life Sciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3896 holding.
  • GAMMA Investing first reported a position in Anavex Life Sciences in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Anavex Life Sciences position peaked at $24K in Q1 2025.
  • 24 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.